Ethicon Inc.
Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line.
Ethicon has manufactured surgical sutures and wound closure devices for over a century. After World War II, Ethicon’s market share in surgical sutures rose from 15% to 70% worldwide. In the United States, the market share is approximately 80%. The most popular Ethicon sutures remain Prolene, Monocryl, Vicryl, and Ethilon.
Ethicon is headquartered in Somerville, New Jersey. It currently conducts business in 52 countries and employs approximately 11,000 people.
Corporate History
In 1992, Ethicon was restructured, and Ethicon Endo-Surgery, Inc. became a separate corporate entity.
During the 1990s, Ethicon diversified into new and advanced products and technologies and formed four different companies under the Ethicon umbrella, each of which specialize in different products.
In November 2008, the wound management business was sold to One Equity Partners and became Systagenix Wound Management Limited.
In 2009, Ethicon acquired breast implant maker Mentor.
Ethicon Companies
- Ethicon products: suture products and suture technology.
- Gynecare: women's health products.
- Acclarent: an ear, nose and throat technology company acquired in 2010.[1]
Further reading
- Lance Williams "How suture maker kept lid on infection suits: Despite recall, Ethicon said product was harmless" San Francisco Examiner February 22, 1999
- recall enforcement, U.S. Food and Drug Administration
References
| ||||||||||||||||||
